Excelsior Medical Co., Ltd. (TPE:4104)
Taiwan · Delayed Price · Currency is TWD 84.80
-3.60 (-4.07%)
Sep 9, 2025, 2:36 PM CST
Excelsior Medical Market Cap
Excelsior Medical has a market cap or net worth of 14.55 billion as of September 9, 2025. Its market cap has increased by 3.19% in one year.
Market Cap
14.55B
Enterprise Value
15.64B
Revenue
8.65B
Ranking
n/a
PE Ratio
18.47
Stock Price
84.80
Market Cap Chart
Since July 3, 2003, Excelsior Medical's market cap has increased from 2.50B to 14.55B, an increase of 482.21%. That is a compound annual growth rate of 8.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 14.55B | 3.53% |
| Dec 31, 2024 | 14.05B | 2.15% |
| Dec 29, 2023 | 13.76B | 37.31% |
| Dec 30, 2022 | 10.02B | 23.23% |
| Dec 30, 2021 | 8.13B | 2.67% |
| Dec 31, 2020 | 7.92B | 14.64% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 395.51B |
| PharmaEssentia | 177.30B |
| Bora Pharmaceuticals Co., LTD. | 91.34B |
| Lotus Pharmaceutical | 50.62B |
| Lumosa Therapeutics | 44.05B |
| Oneness Biotech | 36.68B |
| Polaris Group | 29.89B |
| Pell Bio-Med Technology | 28.68B |